EnTRINSIC - EnPulse Trial on Search AV+ Influence

NCT00157794 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2025-07-03

No results posted yet for this study

Summary

Right ventricular apical pacing in patients treated with a pacemaker is unnecessary in cases where patients have stable atrioventricular (AV)-conduction. Recent findings demonstrate that pacing even might have unfavourable effects, especially if patients suffer from additional cardiac diseases such as heart failure. The Search AV+ algorithm was designed to avoid ventricular pacing and support intrinsic AV-conduction in order to avoid possible detrimental effects of right ventricular apical pacing. The goal of the EnTRINSIC study is to assess the amount of ventricular stimulation, the amount of hospitalizations, the occurrence of atrial fibrillation and the usage of drugs in patients treated with pacemakers with an activated Search AV+ algorithm versus patients treated with an individual optimization of the pacemaker settings to minimize the amount of right ventricular pacing.

Conditions

  • Arrhythmia, Sinus

Interventions

DEVICE

Search AV+ algorithm

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY
  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Michael Jakob, MD · Knappschaftskrankenhaus Sulzbach

  • Peter Lamm, MD · Klinikum der Universität München Großhadern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00157794 on ClinicalTrials.gov